Noninvasive multimodal wearable biomonitor engineered for continuous physiological monitoring and translational validation. The adjustable arm-mounted platform integrates advanced biosensing modules to enable real-time assessment of cardiovascular, metabolic, and hemodynamic function while serving as a scalable test system for the development and deployment of next-generation wearable health technologies.
This research focuses on developing a fully noninvasive, multimodal wearable biosensing platform that enables continuous, real-world physiological monitoring and predictive health intelligence. The system integrates a comprehensive suite of sensing modalities, including photoplethysmography, bioimpedance, electrocardiography, electrodermal activity, temperature sensing, inertial motion tracking, and mechanical physiological sensing within a compact and ergonomic upper-arm wearable architecture. By simultaneously capturing electrical, optical, mechanical, and autonomic signals, the platform provides a synchronized, high-resolution representation of cardiovascular, metabolic, and systemic dynamics without invasive measurements.
A major focus of this platform is the early identification and prediction of metabolic instability, including both hyperglycemic and hypoglycemic events. Rather than relying on a single biochemical marker, the system leverages multimodal physiological signatures that reflect vascular responses, autonomic nervous system activation, perfusion changes, and metabolic stress. Advanced machine learning and signal fusion algorithms analyze these complex physiological interactions to enable predictive detection of glycemic excursions before severe clinical manifestations occur, supporting next-generation approaches to metabolic health monitoring.
Integrated multimodal sensing architecture deployed on the upper arm, combining single-sided ECG, bioimpedance and electrodermal activity, optical perfusion sensing, temperature monitoring, and inertial motion tracking to enable comprehensive, noninvasive characterization of cardiovascular performance, metabolic state, and dynamic physiological response.
Beyond continuous monitoring, the platform serves as a flexible translational test system for the rapid development and validation of emerging wearable biosensing technologies, multimodal signal fusion strategies, and AI-driven physiological modeling. Its modular design enables integration of new sensing concepts and supports applications spanning diabetes management, cardiovascular risk assessment, human performance optimization, rehabilitation monitoring, and autonomous health systems for clinical, consumer, military, and aerospace environments.
Designed for scalability, comfort, and real-world deployment, this noninvasive biosensing ecosystem represents a transition from episodic measurement toward predictive, personalized physiological intelligence, enabling earlier intervention, improved situational awareness, and enhanced long-term health outcomes.